Finance

Lists
Why is KN0 up 7,33%?
Dive Deeper
KN0:FRA
Dicot Pharma AB
€0,016
+7,33%
(+0,0011) 1D
9 Okt., 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for KN0...
Open
€0,02
High
€0,02
Low
€0,02
Mkt. cap
873,31 m
Avg. vol.
0,00
Volume
0,00
52-wk high
€0,11
52-wk low
€0,01
No. of employees
4
Open
€0,02
High
€0,02
Low
€0,02
Mkt. cap
873,31 m
Avg. vol.
0,00
Volume
0,00
52-wk high
€0,11
52-wk low
€0,01
No. of employees
4
News stories
From web sources and news partners
About Dicot Pharma AB
CEO-
Employees4
Founded2015
Headquarters-
SectorPharmaceutical industry
Websitedicotpharma.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16,60 m
17,24 m
15,00 m
18,40 m
Operating expense
16,60 m
17,32 m
15,10 m
18,70 m
Total operating expenses
16,60 m
17,32 m
15,10 m
18,70 m
Operating income
-16,60 m
-17,32 m
-15,10 m
-18,70 m
Other non operating income
-
-99,00 k
-
100,00 k
EBT including unusual items
-16,10 m
-16,84 m
-14,80 m
-18,40 m
EBT excluding unusual items
-16,10 m
-16,84 m
-14,80 m
-18,40 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
86,00 k
100,00 k
300,00 k
Net income
-16,10 m
-16,84 m
-14,80 m
-18,40 m
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
500,00 k
429,00 k
300,00 k
200,00 k
Interest expense
-
-6,00 k
-
-
Net interest expenses
500,00 k
423,00 k
300,00 k
200,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-16,60 m
-17,32 m
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme